Demetra Holding Acquires Majority Stake in GetSet Surgical, Expanding Spine Portfolio
Demetra Holding, a global leader in providing anti-infective cements, spacers, and biomaterials for orthopedic applications, has announced the acquisition of a 51% stake in GetSet Surgical, a Swiss-based provider of innovative spine surgical solutions. This strategic acquisition represents a major step in Demetra’s efforts to expand its footprint in the spine sector and create a comprehensive product lineup designed to reduce infection risks, optimize hospital efficiency, and promote environmental sustainability.
Strategic Benefits of the Acquisition
The collaboration between Demetra Holding and GetSet Surgical combines the strengths of both companies to offer an integrated approach to spine and orthopedic procedures. A key feature of this partnership is the use of sterile-packaged disposable implants and instruments, which help reduce the risk of infections and lower hospital costs related to central sterilization issues. This aligns perfectly with Demetra’s broader mission of becoming the company of choice for infection management and efficiency in the healthcare sector. Demetra’s portfolio companies, including Tecres, OSARTIS, OsteoRemedies, and Yijiutai, will now benefit from this new acquisition, creating a stronger, more diverse set of offerings in the orthopedic and spine markets.
The acquisition also brings the promise of improved operational efficiency. By integrating GetSet Surgical’s expertise in sterile spine procedure kits with Demetra’s existing technologies, the two companies will be able to provide solutions that not only enhance patient safety but also streamline hospital operations. Additionally, both companies are committed to driving sustainability in healthcare, an objective that has become increasingly important in the industry.
Michele Perrino, CEO of Demetra Holding, commented on the acquisition: “Demetra Holding is proud to spearhead this collaboration, which perfectly aligns with our mission to enhance healthcare solutions focused on orthopedic infection management strategies worldwide. By combining the innovative capabilities of GetSet Surgical with our existing product offerings, we aim to create the premier choice for surgeons and their patients in the sterile, single-use packaged spinal procedure market.”
Ole Stoklund, founder and CEO of GetSet Surgical, also expressed enthusiasm about the partnership: “The integration of GetSet’s cutting-edge sterile packaged spine procedure kits with Demetra Holding’s robust portfolio and resources will significantly enhance our mutual commitment to minimizing infection risks and optimizing operational efficiencies in hospitals and the emerging ASC market.”
Focus on Global Expansion and U.S. Market Introduction
As part of its global growth strategy, Demetra Holding is prioritizing the introduction of GetSet’s products into the U.S. market. The distribution of these products will be managed by Demetra’s portfolio company, OsteoRemedies, through its newly established U.S. Spine Division. This division will be led by Ted Bird, an industry veteran recently appointed Vice President of Spine Commercial.
The initial U.S. product offerings will include GetSet’s GoPLF!™ Posterior Lateral Fusion system, which is already FDA-approved. Demetra also anticipates the launch of GetSet’s GoLIF!™ Lumbar Interbody Fusion system later this year, once the product secures FDA 510(k) clearance. Furthermore, the companies plan to expedite the development and introduction of additional systems to meet the growing demand for advanced spine surgery solutions.
Integration into Demetra’s Global Infrastructure
Beyond the U.S., Demetra Holding is committed to expanding GetSet Surgical’s innovative products across its global infrastructure. Both the GoPLF!™ and GoLIF!™ systems are already CE-marked and available for distribution in European and other international markets. By leveraging Demetra’s extensive global infrastructure, GetSet Surgical’s products will be more widely accessible, improving patient outcomes and driving efficiency in healthcare delivery across key global markets.
Demetra Holding’s dedication to infection prevention and control is reflected in its ongoing efforts to improve healthcare products and services. This acquisition will further strengthen Demetra’s position as a leader in the global orthopedic and spine market.
About Demetra Holding SpA
Headquartered in Milan, Italy, Demetra Holding is an international leader in aggregating innovative healthcare companies focused on improving lives through advanced products, particularly in the areas of infection prevention and control. By acquiring companies like GetSet Surgical, Demetra continues to expand its capabilities, ensuring it remains at the forefront of providing cutting-edge medical solutions in the orthopedic and spine sectors. Through its portfolio, Demetra Holding aims to offer integrated solutions that enhance patient safety, hospital efficiency, and environmental sustainability, positioning the company as a global leader in the healthcare industry.
